Biotechnology Sanofi, expanding in radiopharma, strikes a joint venture deal The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand. Written by Ned Pagliarulo October 17, 2024October 17, 2024 Saving Bookmark this article Bookmarked
Biotechnology New patent expiration for United Therap drug ORENITRAM Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for ORENITRAM. This drug has fifty-nine patent […] Written by DrugPatentWatch – Make Better Decisions October 14, 2024October 14, 2024 Saving Bookmark this article Bookmarked
Biotechnology The biggest private biotech investments in September 2024 The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024. Around the world, oncology, immunology, and infectious disease players attracted the biggest funding rounds overall. Biggest biotech investments by value in September 2024 When looking at September’s biggest private biotech investments, we can see that the top spot went […] Written by Willow Shah-Neville October 7, 2024October 7, 2024 Saving Bookmark this article Bookmarked
Biotechnology Roche turns to a startup in search for new breast cancer drugs The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly. Written by Jonathan Gardner September 30, 2024September 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology New tentative approval for Alembic drug dabigatran etexilate mesylate Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […] Source Source Written by DrugPatentWatch – Make Better Decisions September 27, 2024September 27, 2024 Saving Bookmark this article Bookmarked
Biotechnology A new role for intelligent tutors powered by AI in brain surgery? Neurosurgery is perhaps one of the most demanding professions in healthcare. Surgeons spend long hours performing operations where expert performance means the difference between a good and bad patient outcome. While operative injuries are rare, when they occur, they can have serious, and lifelong consequences. Neurosurgery is perhaps one of the most demanding professions in […] Written by Admin September 24, 2024September 24, 2024 Saving Bookmark this article Bookmarked
Biotechnology what biotech has to offer Menopause marks the end of periods and fertility and is regarded as a natural part of aging. Occurring typically between the ages of 45 and 50, this period comes with a host of difficult symptoms due to the drop in hormone levels. However, a new drug could relieve some of these symptoms for millions of […] Written by Roohi Mariam Peter September 20, 2024September 20, 2024 Saving Bookmark this article Bookmarked
Biotechnology Austria wants to be at the top of the podium in research and development In 2023, the share of R&D expenditure in Austria’s nominal gross domestic product (GDP) was 3.26%. This put Austria in third place in the EU after Belgium and Sweden. In 2024, the ratio will be 3.34% according to the estimate global by Statistics Austria, corresponding to a record sum of 16.64 billion euros. The Federal […] Written by Arno Fricke September 17, 2024September 17, 2024 Saving Bookmark this article Bookmarked
Biotechnology Moderna, trailing rivals, checks its RSV shot expectations During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year. Written by Delilah Alvarado September 14, 2024September 14, 2024 Saving Bookmark this article Bookmarked
Biotechnology Which pharmaceutical drugs have the most drug patents in Austria? Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. The companies with the greatest patent coverage in Austria are: Adasuve Abilify Maintena Kit Vistogard Zetia Abilify Nucynta […] Written by DrugPatentWatch – Make Better Decisions September 10, 2024September 10, 2024 Saving Bookmark this article Bookmarked
VU Researchers Publish Study on the Mechanism of CRISPR-Cas “Protein Scissors” in Molecular Cell CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and functions. Among them, the most studied proteins today are Cas9 and Cas12, also known as DNA or gene ‘scissors’, which have revolutionized the field of genome editing, enabling scientists to […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Visualizing ER-phagy and ER architecture in vivo ER-phagy is an evolutionarily conserved mechanism crucial for maintaining cellular homeostasis. However, significant gaps persist in our understanding of how ER-phagy and the ER network vary across cell subtypes, tissues, and organs. Furthermore, the pathophysiological relevance of ER-phagy remains poorly elucidated. Addressing these questions requires developing quantifiable methods to visualize ER-phagy and ER architecture in […] Written by Admin November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
VU Researchers Publish Study on the Mechanism of CRISPR-Cas “Protein Scissors” in Molecular Cell CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and functions. Among them, the most studied proteins today are Cas9 and Cas12, also known as DNA or gene ‘scissors’, which have revolutionized the field of genome editing, enabling scientists to […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Visualizing ER-phagy and ER architecture in vivo ER-phagy is an evolutionarily conserved mechanism crucial for maintaining cellular homeostasis. However, significant gaps persist in our understanding of how ER-phagy and the ER network vary across cell subtypes, tissues, and organs. Furthermore, the pathophysiological relevance of ER-phagy remains poorly elucidated. Addressing these questions requires developing quantifiable methods to visualize ER-phagy and ER architecture in […] Written by Admin November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Workers and the just transition Some takes the form of an anti-environmental backlash, instigated or colonised by conservative and far-right forces. While posing as allies of “working families”, they denigrate the most fundamental of workers’ needs: for a habitable planet. Some takes a progressive form, the classic case being the gilets jaunes in France. When Emmanuel Macron’s government hiked “green […] Written by brendan November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked